Analytical Data
-
基因名
EFCAB2
- Application
-
别名
EFCAB2; DRC8Dynein regulatory complex protein 8; EF-hand calcium-binding domain-containing protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5VUJ9
-
表达区间
1-269aa
-
氨基酸序列
MLGPGQVRLR PRVWRDKAGG RVADGASGLP PARGSWRETG TGRALGASSP PRPAQGSSSP GIQSGPSSRP GSPRGAEQAG TPRPRLSLGI SQATGSAARW RTRRTGKGLG YNSDEIRPRT LLIEHLMEGG RRDHHTMTVL WGTQEIIVAE FHKKIKEAFE VFDHESNNTV DVREIGTIIR SLGCCPTEGE LHDLIAEVEE EEPTGYIRFE KFLPVMTEIL LERKYRPIPE DVLLRAFEVL DSAKRGFLTK DELIKYMTEE DGVSLRRPG
-
分子量
29.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EFCAB2, or "EFCAB2 protein," is part of the EF-hand calcium-binding protein family, which plays a crucial role in various cellular processes. Understanding EFCAB2 is significant due to its potential involvement in calcium signaling pathways, which are fundamental for cellular functions including muscle contraction, neurotransmitter release, and gene expression. Research has indicated that EFCAB2 may have specific roles in the regulation of calcium-dependent processes, and its dysregulation has been associated with various diseases, including neurodegenerative disorders and certain cancers. The recombinant expression of EFCAB2 protein allows for in-depth studies of its structure and function, enabling researchers to explore its interaction with calcium and other cellular components. Moreover, recombinant EFCAB2 provides a valuable tool for drug discovery and the development of therapeutic interventions targeting calcium homeostasis. By utilizing advanced techniques such as protein purification and structural analysis, scientists aim to elucidate the mechanisms underlying EFCAB2's involvement in health and disease, thereby paving the way for novel therapeutic strategies. As research continues to unfold, EFCAB2 stands out as a significant focus in the field of molecular biology and biochemistry, highlighting the importance of understanding calcium signaling in the maintenance of cellular integrity and function.
